ISPC · XBRL financial data

iSpecimen financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (ISPC's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Oct 31, 2024	Q4 FY24†Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25†Dec 31, 2025	Q1 FY26†Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	—	year only	2,290	2,864	—	1,476*	1,058	713	107	52*	156	152
Revenue from contracts with customers	2,778	2,575*	2,290	2,864	—	—	—	—	—	—	—	—
Cost of revenue	—	year only	952	1,377*	—	1,276*	609	396*	157*	551*	—	—
Cost of goods and services sold	1,393	1,427*	1,000	1,424	—	1,324*	657	444	205	599*	84	83
Research and development	—	year only	—	—	—	year only	—	—	—	—	—	—
General and administrative	1,102	1,413*	2,104	1,055	—	2,015*	759	948	864	901*	680	443
Operating income (loss)	(2,194)	(2,871)*	(3,001)	(2,182)	—	(5,840)*	(1,638)	(1,821)	(2,830)	(2,688)*	(2,538)	(1,363)
Interest income	—	—	30	9	—	3*	3	0	0	0*	0	0
Interest expense	4	4*	4	4	—	157*	2	0*	0	0*	—	—
Other income (expense)	20	(30)*	72	68	—	(6)*	(2)	764	47	(2,313)*	264	(0)
Net income (loss)	(2,111)	(3,073)*	(2,902)	(2,109)	—	(6,047)*	(1,658)	(1,047)	(2,781)	(5,001)*	(2,275)	(1,363)
Earnings per share, basic‡ USD per share	(92.00)	(136.00)*	(128.00)	(76.00)	—	—	(0.71)	(0.42)	(0.48)	—	(6.66)	(0.98)
Earnings per share, diluted‡ USD per share	(92.00)	(136.00)*	(128.00)	(3.72)	—	—	(0.71)	(0.42)	(0.48)	—	(6.66)	(0.98)
Weighted average shares, basic‡ thousands of shares	23	23*	23	28	—	—	2,323	2,497	5,840	—	341	1,394
Weighted average shares, diluted‡ thousands of shares	23	23*	23	567	—	—	2,323	2,497	5,840	—	341	1,394

‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (September 2024); filings made before it reported them unadjusted.
‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (October 2024); filings made before it reported them unadjusted.
† Share count changed about 52x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 3x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 1/21 in the period ending 2026-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (ISPC's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Oct 31, 2024	Q4 FY24†Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25†Dec 31, 2025	Q1 FY26†Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	2,722	2,344	2,090	2,151	—	1,878	783	589	2,783	6,881	2,819	4,414
Marketable securities	2,941	2,662	466	0	—	—	—	—	—	—	—	—
Accounts receivable	1,706	728	437	893	—	1,445	582	372	121	48	133	21
Inventory	—	—	—	—	—	45	—	—	—	—	—	—
Prepaid and other current assets	321	292	314	238	—	265	164	205	698	25	532	49
Total current assets	9,127	8,239	5,286	5,235	—	3,588	1,528	1,166	3,602	6,955	3,484	4,485
Property and equipment, net	146	128	121	105	—	94	76	60	43	26	23	21
Right-of-use asset	234	194	153	27	—	328	314	299	284	269	254	238
Total assets	16,295	15,819	12,514	11,902	—	9,350	6,843	6,035	8,998	9,531	6,610	7,393
Accounts payable	2,280	3,925	3,560	4,205	—	4,198	3,786	4,315	4,771	5,363	4,707	4,672
Accrued liabilities	1,028	1,541	1,711	1,319	—	1,169	818	646	717	619	644	619
Current portion of long-term debt	—	—	—	—	1,000	—	—	—	—	—	—	—
Total current liabilities	3,517	6,049	5,701	5,813	—	5,770	4,920	5,172	5,698	6,231	5,600	5,477
Lease liability, non-current	72	29	—	—	—	269	255	241	227	212	196	180
Total liabilities	3,589	6,078	5,701	5,813	—	6,039	5,175	5,413	5,925	6,443	5,796	5,657
Accumulated deficit	(56,292)	(59,365)	(62,267)	(64,376)	—	(71,863)	(73,521)	(74,568)	(77,349)	(82,350)	(84,625)	(85,988)
Total stockholders' equity	12,706	9,741	6,813	6,089	—	3,311	1,669	622	3,073	3,088	814	1,736
Total liabilities and equity	16,295	15,819	12,514	11,902	—	9,350	6,843	6,035	8,998	9,531	6,610	7,393
Common shares outstanding (cover page)‡ thousands of shares	23	23	25	33	48	2,497	2,497	5,539	9,771	29,662	1,437	2,519

‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (September 2024); filings made before it reported them unadjusted.
‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (October 2024); filings made before it reported them unadjusted.
† Share count changed about 52x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 3x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 1/21 in the period ending 2026-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (ISPC's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Oct 31, 2024	Q4 FY24†Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25†Dec 31, 2025	Q1 FY26†Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(2,111)	(3,073)*	(2,902)	(2,109)	—	(6,047)*	(1,658)	(1,047)	(2,781)	(5,001)*	(2,275)	(1,363)
Stock-based compensation	106*	108*	94	80*	—	11*	16	2*	2*	2*	1	0*
Net cash from operating activities	(1,634)*	345*	(2,072)	(1,539)*	—	(3,573)*	(1,096)	(192)*	(2,036)*	(917)*	(3,362)	(690)*
Purchases of property and equipment	6*	0*	9	0*	—	8*	—	—	0*	0*	—	—
Net cash from investing activities	2,351*	(723)*	1,937	295*	—	(73)*	—	—	(1,000)*	0*	(700)	0*
Proceeds from issuing common stock	—	—	138	1,356*	—	(1,096)*	—	—	1,751*	2,250*	—	—
Proceeds from issuing equity	—	—	—	—	—	year only	—	—	—	—	—	—
Share repurchases	—	—	53	0*	—	—	—	—	—	—	—	—
Net cash from financing activities	0*	0*	(119)	1,305*	—	3,772*	—	—	5,230*	5,015*	—	—

† Share count changed about 52x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 3x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 1/21 in the period ending 2026-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 8731 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8731 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
iSpecimen	4,414	152	(690)*	2.5M	6.4 quarters	Q2 FY26 10-QJun 30, 2026
Cannabis Bioscience International Holdings	0.1	11	(15)*	11.6B	0.0 quarters	Q3 FY26 10-QFeb 28, 2026
Hypha Labs	5.1	not reported	(52)*	163.9M	0.1 quarters	Q3 FY26 10-QJun 30, 2026
Foxo Technologies	58	4,715	299*	1.7M	—	Q2 FY26 10-QJun 30, 2026
Weed	1.1	0	(19)*	148.3M	0.1 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.